January 3rd, 2012
Bariatric Surgery Cuts Cardiovascular Deaths and Events
Larry Husten, PHD
Bariatric surgery results in significant reductions in cardiovascular deaths and events, according to a new study from Sweden published in JAMA. But one expert cautions that the results do not mean that obese patients without other weight-related complications should undergo surgery.
Analyzing data from more than 4000 obese patients enrolled in the ongoing Swedish Obese Subjects (SOS) study, Lars Sjöström and colleagues found that bariatric surgery was associated with a reduction in cardiovascular events and deaths after a median follow-up of 14.7 years. (The investigators had previously reported a reduction in total mortality in the surgery group.)
- CV deaths: 28 in the surgery group versus 49 in the control group (HR 0.47, CI 0.29- 0.76, p=0.002)
- MI or stroke: 199 versus 234, (HR 0.67, CI 0.54-0.83, p<0.001)
In a surprising finding, the investigators found no significant association between either weight at baseline or weight loss after surgery and cardiovascular events. The authors speculate this may have been due to the low statistical power of the study to detect an association or, alternatively, that the greatest benefit was derived from the initial modest weight loss caused by the surgery.
Taken with previous reports, the results, write the authors, “demonstrate that there are many benefits to bariatric surgery and that some of these benefits are independent of the degree of the surgically induced weight loss.”
In an accompanying editorial, Edward Livingston writes that “because the expected health benefits do not necessarily exceed the risks of weight loss operations, obese patients without other weight-related complications generally should not undergo bariatric surgery.” He suggests that the NIH convene a new expert panel “to rigorously assess the available evidence and provide updated recommendations for bariatric procedures for the treatment of obesity.”
Categories: Cardiac Surgery, General, Prevention
Tags: bariatric surgery, weight loss
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Paving the Road toward Targeted Lipid Lowering April 9, 2026In patients with atherosclerotic cardiovascular disease, lowering lipid levels is critical for reducing the risk of recurrent cardiovascular disease. International guidelines endorse the targeting of a low-density lipoprotein (LDL) cholesterol level of less than 55 mg per deciliter for secondary prevention of atherosclerotic cardiovascular disease in patients at high risk...
- Case 10-2026: A 70-Year-Old Woman with a Racing Heart, Fatigue, and Dyspnea April 9, 2026A 70-year-old woman presented with a racing heart, fatigue, dyspnea, and leg edema. One month earlier, percutaneous catheter ablation for atrial fibrillation had been performed. A diagnosis was made.
- Systems-Based Success for Hypertension April 9, 2026In 2022, more than 130,000 deaths in the United States were primarily attributable to high blood pressure and were largely preventable; this number represents a near doubling since 2012.1 Despite the availability of multiple effective, safe, and inexpensive therapies for lowering blood pressure, fewer than half of U.S....
- Multifaceted Strategies for Hypertension Control in Low-Income Patients April 9, 2026Among low-income patients with hypertension, a multifaceted, team-based strategy resulted in a greater reduction in systolic blood pressure than enhanced usual care.
- Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease April 9, 2026Among patients with atherosclerotic cardiovascular disease, targeting an LDL cholesterol level below 55 mg per deciliter led to a lower 3-year risk of cardiovascular events than targeting a level below 70 mg per deciliter.
- Paving the Road toward Targeted Lipid Lowering April 9, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
